Successful Steroid Therapy for Lipoid Pneumonia Developing After Allogeneic Hematopoietic Stem Cell Transplant: A Case Report

M. Sakurai, J. Kato, T. Toyama, R. Hashida, Y. Yamane, R. Abe, Y. Koda, S. Kohashi, T. Kikuchi, Y. Hayashi, S. Nukaga, Soichiro Ueda, K. Fukunaga, S. Okamoto, T. Mori

Research output: Contribution to journalArticle


Lipoid pneumonia is an uncommon noninfectious inflammatory lung disease characterized by lipid deposition in the alveoli, and its etiology and treatment have not been elucidated. We report the case of a 32-year-old woman who developed lipoid pneumonia 9 months after allogeneic hematopoietic stem cell transplant for chronic myelogenous leukemia in lymphoid blast crisis. She complained of progressive cough and dyspnea shortly after discontinuation of immunosuppressive therapy given for graft-vs-host disease. Computed tomography demonstrated diffuse ground-glass opacities in the lungs, and pulmonary function test revealed restrictive impairment. Bronchoalveolar lavage fluid showed milky appearance, and transbronchial lung biopsy specimen revealed foamy macrophages infiltrating the alveoli. Based on these findings, she was diagnosed as having lipoid pneumonia. Prednisolone (1 mg/kg/d) promptly improved the symptoms, pulmonary shadows, and pulmonary function. The findings and clinical course of this case suggest that lipoid pneumonia should be recognized as one of the pulmonary complications of allogeneic hematopoietic stem cell transplantation.

Original languageEnglish
Pages (from-to)4096-4098
Number of pages3
JournalTransplantation Proceedings
Issue number10
Publication statusPublished - 2018 Dec 1


ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this